aap

Strong sales increase (+23%) and EBITDA growth (>100%) in Q2; growth driver LOQTEQ® and Biomaterials - Seite 3

As reported in the press release dated June 2, 2014, the 50% share disposal of the remaining stakes in the dental joint venture aap BM productions GmbH will have an immediate loss in sales for the full financial year 2014 of approx. EUR 1 million. The management of aap Implantate AG has identified certain upside potentials that may compensate the negative sales effect. For the time being, the current sales and EBITDA forecast for the financial year 2014 remains in tact: Total sales of EUR 35 million and an EBITDA between EUR 5 million and EUR 6 million.

_________________

aap Implantate AG (ISIN DE0005066609) - Prime Standard/Regulated Market - All German stock markets -

About aap Implantate AG
aap is a global medical device company headquartered in Berlin, Germany that develops, manufactures and markets innovative biomaterials and implants that are used in orthopedic procedures. The Company's products, which include a full line of plating systems, cannulated screws and bone cement products, are primarily used in the orthopedic specialty areas of trauma and spine repair. The Company's products are sold through its direct sales force, distribution partners and license agreements with OEM partners. aap's stock is listed in the Prime Standard segment of the Frankfurt Stock Exchange. For more information, please visit www.aap.de, or download the Company's investor relations app from the Apple's App Store or Google Play.

Forward-looking statement
This release may contain forward-looking statements based on current experience, estimates and projections of the management board and currently available information. They are not guarantees of future performance. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. Many factors could cause the actual results, performance or achievements of aap to be materially different from those that may be expressed or implied by such statements. These factors include those discussed in aap's public reports. Forward-looking statements therefore speak only as of the date they are made. aap does not assume any obligation to update the forward-looking statements contained in this release or to conform them to future events or developments.